da Vinci Xi
The da Vinci Surgical System, approved by the Food and Drug Administration (FDA) in 2000, operates in hospitals worldwide with 3,102 installed units until June 2014, namely 2,153 in the United States, 499 in Europe, 183 in Japan, and 267 in the rest of the world, and estimated 200,000 surgeries conducted in 2012. The system is commonly used for prostatectomies and gynecologic surgical procedures, but is increasingly used also for cardiac valve repair. Nowadays, the da Vinci System has brought minimally invasive surgery to more than 3 million patients worldwide and is used for cardiac, colorectal, general, gynecologic, head & neck, thoracic and urologic surgery.
The main enhanced features of the da Vinci technology, with respect to the previous versions (dVRK), are the highly magnified 3D high-definition vision system with fluorescence imaging capabilities, the EndoWrist instrumentation and intuitive motion using tiny wristed instruments that bend and rotate far greater than the human hand, powered robotic technology that allows the surgeon’s hand movements to be scaled, filtered and translated into precise movements of the EndoWrist instruments working inside the patient’s body, a patient-side cart with four interactive robotic arms (PSM) controlled from the console, ergonomics of the surgeon console. As a result, da Vinci enables surgeons to operate with enhanced vision, precision and control. Finally the new advanced offered technology is the da Vinci Xi Skills Simulator that allows surgeons to practice the skills required to effectively use the da Vinci Surgical System and offers patient cart simulation capabilities designed to train the perioperative staff.
The da Vinci XI Surgical System is functioning in the operating section of ICAROS since January 2016. As of July 2016, the system has been used for 50 urologic interventions, 15 gynecologic interventions and 15 general surgery interventions. Another 120 interventions are planned until the end of the year.